These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22648296)

  • 1. The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.
    Bosworth CR; Levin G; Robinson-Cohen C; Hoofnagle AN; Ruzinski J; Young B; Schwartz SM; Himmelfarb J; Kestenbaum B; de Boer IH
    Kidney Int; 2012 Sep; 82(6):693-700. PubMed ID: 22648296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites.
    Dai B; David V; Alshayeb HM; Showkat A; Gyamlani G; Horst RL; Wall BM; Quarles LD
    Kidney Int; 2012 Nov; 82(10):1061-70. PubMed ID: 22739976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials.
    de Boer IH; Sachs MC; Chonchol M; Himmelfarb J; Hoofnagle AN; Ix JH; Kremsdorf RA; Lin YS; Mehrotra R; Robinson-Cohen C; Siscovick DS; Steffes MW; Thummel KE; Tracy RP; Wang Z; Kestenbaum B
    Am J Kidney Dis; 2014 Aug; 64(2):187-97. PubMed ID: 24703961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin d, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study.
    Jassal SK; Chonchol M; von Mühlen D; Smits G; Barrett-Connor E
    Am J Med; 2010 Dec; 123(12):1114-20. PubMed ID: 20870200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Vitamin D
    Batacchi Z; Robinson-Cohen C; Hoofnagle AN; Isakova T; Kestenbaum B; Martin KJ; Wolf MS; de Boer IH
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1498-1506. PubMed ID: 28768705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic Study.
    Hsu S; Zelnick LR; Lin YS; Best CM; Kestenbaum B; Thummel KE; Rose LM; Hoofnagle AN; de Boer IH
    J Am Soc Nephrol; 2021 Jan; 32(1):188-198. PubMed ID: 33115916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Effects of Vitamin D Status, Renal Function and Age on Serum Parathyroid Hormone Levels.
    Niculescu DA; Deacu LG; Caragheorgheopol A; Popescu N; Ghemigian A; Procopiuc C; Rosca R; Poiana C
    Front Endocrinol (Lausanne); 2021; 12():657991. PubMed ID: 33995282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
    Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population.
    Guessous I; McClellan W; Kleinbaum D; Vaccarino V; Hugues H; Boulat O; Marques-Vidal P; Paccaud F; Theler JM; Gaspoz JM; Burnier M; Waeber G; Vollenweider P; Bochud M
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1162-9. PubMed ID: 25901090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Parathyroid Hormone, 25 (OH) Vitamin D, and Chronic Kidney Disease: A Population-Based Study.
    Wang WH; Chen LW; Lee CC; Sun CY; Shyu YC; Hsu HR; Chien RN; Wu IW
    Biomed Res Int; 2017; 2017():7435657. PubMed ID: 28367447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD.
    Ureña-Torres P; Metzger M; Haymann JP; Karras A; Boffa JJ; Flamant M; Vrtovsnik F; Gauci C; Froissart M; Houillier P; Stengel B;
    Am J Kidney Dis; 2011 Oct; 58(4):544-53. PubMed ID: 21803465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.
    Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis.
    Bansal N; Zelnick L; Robinson-Cohen C; Hoofnagle AN; Ix JH; Lima JA; Shoben AB; Peralta CA; Siscovick DS; Kestenbaum B; de Boer IH
    J Am Heart Assoc; 2014 Dec; 3(6):e001278. PubMed ID: 25468653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
    Ennis JL; Worcester EM; Coe FL; Sprague SM
    J Nephrol; 2016 Feb; 29(1):63-70. PubMed ID: 25736620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)
    Kritmetapak K; Losbanos L; Berent TE; Ashrafzadeh-Kian SL; Algeciras-Schimnich A; Hines JM; Singh RJ; Kumar R
    BMC Nephrol; 2021 Mar; 22(1):114. PubMed ID: 33784965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 1,25-dihydroxyvitamin D Better Reflects Renal Parameters Than 25-hydoxyvitamin D in Patients with Glomerular Diseases.
    Chung S; Kim M; Koh ES; Hwang HS; Chang YK; Park CW; Kim SY; Chang YS; Hong YA
    Int J Med Sci; 2017; 14(11):1080-1087. PubMed ID: 29104461
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study.
    Hsu S; Zelnick LR; Bansal N; Brown J; Denburg M; Feldman HI; Ginsberg C; Hoofnagle AN; Isakova T; Leonard MB; Lidgard B; Robinson-Cohen C; Wolf M; Xie D; Kestenbaum BR; de Boer IH;
    J Am Heart Assoc; 2023 Jul; 12(14):e028561. PubMed ID: 37421259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study.
    Mariani LH; White MT; Shults J; Anderson CA; Feldman HI; Wolf M; Reese PP; Denburg MR; Townsend RR; Lo JC; Cappola AR; Carlow D; Gadegbeku CA; Steigerwalt S; Leonard MB;
    J Ren Nutr; 2014 May; 24(3):186-93. PubMed ID: 24613295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D metabolites and bone mineral density: The multi-ethnic study of atherosclerosis.
    van Ballegooijen AJ; Robinson-Cohen C; Katz R; Criqui M; Budoff M; Li D; Siscovick D; Hoofnagle A; Shea SJ; Burke G; de Boer IH; Kestenbaum B
    Bone; 2015 Sep; 78():186-93. PubMed ID: 25976951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifiers of Plasma 25-Hydroxyvitamin D and Chronic Kidney Disease Outcomes in Black Americans: The Jackson Heart Study.
    Lunyera J; Davenport CA; Pendergast J; Musani SK; Bhavsar NA; Sims M; Mwasongwe S; Wolf M; Diamantidis CJ; Boulware LE; Scialla JJ
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2267-2276. PubMed ID: 30668751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.